Company intelligence / Profile preview

YorkTest

York, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

YorkTest markets CE-marked, in vitro diagnostic finger-prick blood tests for food-specific IgG and IgE to identify individual food sensitivities and allergies, with over 500,000 tests performed and scientific publications supporting their approach. Their most significant study (Hardman & Hart, 2007) showed reductions in symptoms with IgG-guided elimination diets.

Therapeutic areas: GastroenterologyOtherImmunology
Modalities: Diagnostic testDevice
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on YorkTest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YorkTest.

Explore the full profile